News

UConn researchers have demonstrated that a novel protein-based nanoparticle can make mRNA vaccines more effective in tackling a troublesome pathogen in chickens.

New research has found that adding IL-12, a cytokine produced by various immune cells, to mRNA vaccines improves T-cell responses. This could make the benefits of vaccines last longer.

Researchers have discovered inherited genetic differences which could explain why some patients with the deadliest form of skin cancer do not respond to the latest cancer treatments.

A new AI model developed by researchers at Johns Hopkins University and Duke University has demonstrated improved performance in predicting the spread of infectious diseases.

The FDA’s approval was supported by two Phase 3 clinical studies, which showed that the ENCELTO implant slowed the loss of light-sensing retinal cells in people with macular telangiectasia type 2 over a 24-month period.

A new gene therapy treatment developed by UC San Diego works by reprogramming the behavior of diseased brain cells.

A global study, covering more than 230 million people, sheds light on the relationship between Guillain-Barré syndrome after certain Covid vaccines or SARS-CoV-2 infection.

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study.

Scientists have used machine learning to improve the efficacy and safety of targeted cell and gene therapies by potentially using our own proteins. This tool could help to design proteins that avoid unwanted immune responses.

Research from Martin Luther University suggests the asthma drug theophylline helps reduce symptoms in ADCY5-related dyskinesia, a rare genetic movement disorder. Most patients reported fewer involuntary movements, improved walking and better sleep.